Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. (Q40456758)
Jump to navigation
Jump to search
scientific article published on March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. |
scientific article published on March 2007 |
Statements
1 reference
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody. (English)
1 reference
Keith T Flaherty
1 reference
Amy Kramer
1 reference
Maryann Gallagher
1 reference
Robert H Vonderheide
1 reference
Magi Khalil
1 reference
Molly S Stumacher
1 reference
David L Bajor
1 reference
Natalie A Hutnick
1 reference
Patricia Sullivan
1 reference
J Joseph Mahany
1 reference
Stephanie J Green
1 reference
Peter J O'Dwyer
1 reference
Kelli L Running
1 reference
Richard D Huhn
1 reference
Scott J Antonia
1 reference
1 March 2007
1 reference
1 reference
Identifiers
1 reference